Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 47

    1.

    Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study.

    A B E, Denig P, van Vliet T, Dekker JH.

    BMC Fam Pract. 2009 Apr 21;10:24.PMID: 19383116 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Perceived medication adverse effects and coping strategies reported by chronic heart failure patients.

    De Smedt RH, Denig P, Haaijer-Ruskamp FM, Jaarsma T.

    Int J Clin Pract. 2009 Feb;63(2):233-42.PMID: 19196362 [PubMed - in process]Related articles

    3.

    Comparison of various measures for assessing medication refill adherence using prescription data.

    Vink NM, Klungel OH, Stolk RP, Denig P.

    Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):159-65.PMID: 19109809 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prescribing quality indicators of type 2 diabetes mellitus ambulatory care.

    Martirosyan L, Braspenning J, Denig P, de Grauw WJ, Bouma M, Storms F, Haaijer-Ruskamp FM.

    Qual Saf Health Care. 2008 Oct;17(5):318-23.PMID: 18842968 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes.

    Voorham J, Denig P, Wolffenbuttel BH, Haaijer-Ruskamp FM.

    Med Care. 2008 Feb;46(2):133-41.PMID: 18219241 [PubMed - indexed for MEDLINE]Related articles

    6.

    Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes.

    Voorham J, Haaijer-Ruskamp FM, Stolk RP, Wolffenbuttel BH, Denig P; Groningen Initiative to Analyze Type 2 Diabetes Treatment Group.

    Diabetes Care. 2008 Mar;31(3):501-3. Epub 2007 Dec 10.PMID: 18070994 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study.

    Greving JP, Denig P, de Zeeuw D, Bilo HJ, Haaijer-Ruskamp FM.

    Cardiovasc Diabetol. 2007 Sep 20;6:25.PMID: 17883840 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Computerized extraction of information on the quality of diabetes care from free text in electronic patient records of general practitioners.

    Voorham J, Denig P.

    J Am Med Inform Assoc. 2007 May-Jun;14(3):349-54. Epub 2007 Feb 28.PMID: 17329733 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Claims in advertisements for antihypertensive drugs in a Dutch medical journal.

    Greving JP, Denig P, de Zeeuw D, Haaijer-Ruskamp FM.

    J Hypertens. 2007 Mar;25(3):713-22.PMID: 17278989 [PubMed - indexed for MEDLINE]Related articles

    10.

    An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice.

    Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM.

    J Eval Clin Pract. 2006 Dec;12(6):613-21.PMID: 17100860 [PubMed - indexed for MEDLINE]Related articles

    11.

    Determinants for the adoption of angiotensin II receptor blockers by general practitioners.

    Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, Haaijer-Ruskamp FM.

    Soc Sci Med. 2006 Dec;63(11):2890-8. Epub 2006 Sep 7.PMID: 16959390 [PubMed - indexed for MEDLINE]Related articles

    12.

    The impact of new insights and revised practice guidelines on prescribing drugs in the treatment of Type 2 diabetes mellitus.

    Lub R, Denig P, van den Berg PB, Hoogenberg K, de Jong-van den Berg LT.

    Br J Clin Pharmacol. 2006 Dec;62(6):660-5. Epub 2006 Jun 23.PMID: 16796700 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines.

    Mol PG, Denig P, Gans RO, Nannanpanday PV, Degener JE, Laseur M, Haaijer-Ruskamp FM.

    Eur J Clin Pharmacol. 2006 Apr;62(4):297-305. Epub 2006 Jan 24.PMID: 16432716 [PubMed - indexed for MEDLINE]Related articles

    14.

    Physicians' attitudes towards treatment guidelines: differences between teaching and nonteaching hospitals.

    Greving JP, Denig P, de Zeeuw D, Haaijer-Ruskamp FM.

    Eur J Clin Pharmacol. 2006 Feb;62(2):129-33. Epub 2005 Dec 31.PMID: 16389535 [PubMed - indexed for MEDLINE]Related articles

    15.

    Uptake of angiotensin II receptor blockers in the treatment of hypertension.

    Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM.

    Eur J Clin Pharmacol. 2005 Jul;61(5-6):461-6. Epub 2005 May 24.PMID: 15912393 [PubMed - indexed for MEDLINE]Related articles

    16.

    Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?

    Kasje WN, Denig P, de Graeff PA, Haaijer-Ruskamp FM.

    BMC Fam Pract. 2005 May 3;6(1):19.PMID: 15869704 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.

    Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM.

    Eur J Clin Pharmacol. 2005 Apr;61(2):145-51. Epub 2005 Mar 11.PMID: 15761751 [PubMed - indexed for MEDLINE]Related articles

    18.

    Does comorbidity explain trends in prescribing of newer antihypertensive agents?

    Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM.

    J Hypertens. 2004 Nov;22(11):2209-15.PMID: 15480107 [PubMed - indexed for MEDLINE]Related articles

    19.

    Relationship between guideline treatment and health-related quality of life in asthma.

    Pont LG, van der Molen T, Denig P, van der Werf GT, Haaijer-Ruskamp FM.

    Eur Respir J. 2004 May;23(5):718-22.PMID: 15176686 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Physicians' views on joint treatment guidelines for primary and secondary care.

    Kasje WN, Denig P, De Graeff PA, Haaijer-Ruskamp FM.

    Int J Qual Health Care. 2004 Jun;16(3):229-36.PMID: 15150154 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care.

    Schaars CF, Denig P, Kasje WN, Stewart RE, Wolffenbuttel BH, Haaijer-Ruskamp FM.

    Diabetes Care. 2004 Jan;27(1):123-8.PMID: 14693977 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Validity of performance indicators for assessing prescribing quality: the case of asthma.

    Pont LG, Denig P, van der Molen T, van der Veen WJ, Haaijer-Ruskamp FM.

    Eur J Clin Pharmacol. 2004 Jan;59(11):833-40. Epub 2003 Nov 18.PMID: 14624323 [PubMed - indexed for MEDLINE]Related articles

    23.

    Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000.

    Pont LG, Sturkenboom MC, van Gilst WH, Denig P, Haaijer-Ruskamp FM.

    Pharmacoepidemiol Drug Saf. 2003 Jun;12(4):327-34.PMID: 12812013 [PubMed - indexed for MEDLINE]Related articles

    24.

    Connecting pre-marketing clinical research and medical practice: opinion-based study of core issues and possible changes in drug regulation.

    Wieringa NF, Peschar JL, Denig P, de Graeff PA, Vos R.

    Int J Technol Assess Health Care. 2003 Winter;19(1):202-19.PMID: 12701952 [PubMed - indexed for MEDLINE]Related articles

    25.

    Specialists' expectations regarding joint treatment guidelines for primary and secondary care.

    Kasje WN, Denig P, Haaijer-Ruskamp FM.

    Int J Qual Health Care. 2002 Dec;14(6):509-18.PMID: 12515337 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Scope and nature of prescribing decisions made by general practitioners.

    Denig P, Witteman CL, Schouten HW.

    Qual Saf Health Care. 2002 Jun;11(2):137-43.PMID: 12448805 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Variations in asthma treatment in five European countries--judgement analysis of case simulations.

    Wahlström R, Hummers-Pradier E, Lundborg CS, Muskova M, Lagerløv P, Denig P, Oke T, de Saintonge DM; Drug Education Project Group.

    Fam Pract. 2002 Oct;19(5):452-60.PMID: 12356693 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    The value of clinical judgement analysis for improving the quality of doctors' prescribing decisions.

    Denig P, Wahlström R, de Saintonge MC, Haaijer-Ruskamp F.

    Med Educ. 2002 Aug;36(8):770-80.PMID: 12191061 [PubMed - indexed for MEDLINE]Related articles

    29.

    Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data.

    Pont LG, van der Werf GT, Denig P, Haaijer-Ruskamp FM.

    Eur J Clin Pharmacol. 2002 Jan;57(11):819-25.PMID: 11871384 [PubMed - indexed for MEDLINE]Related articles

    30.

    Assessment of new cardiovascular drugs. Relationships between considerations, professional characteristics, and prescribing.

    Wieringa NF, Denig P, de Graeff PA, Vos R.

    Int J Technol Assess Health Care. 2001 Fall;17(4):559-70.PMID: 11758299 [PubMed - indexed for MEDLINE]Related articles

    31.

    Variations in general practitioners' views of asthma management in four European countries.

    Wahlström R, Lagerløv P, Lundborg CS, Veninga CCM, Hummers-Pradier E, Dahlgren LO, Denig P; DEP group. Drug Education Project.

    Soc Sci Med. 2001 Aug;53(4):507-18.PMID: 11459400 [PubMed - indexed for MEDLINE]Related articles

    32.

    Comparison of indicators assessing the quality of drug prescribing for asthma.

    Veninga CC, Denig P, Pont LG, Haaijer-Ruskamp FM.

    Health Serv Res. 2001 Apr;36(1 Pt 1):143-61.PMID: 11324741 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Improving drug treatment in general practice.

    Veninga CC, Denig P, Zwaagstra R, Haaijer-Ruskamp FM.

    J Clin Epidemiol. 2000 Jul;53(7):762-72.PMID: 10941955 [PubMed - indexed for MEDLINE]Related articles

    34.

    Treatment of uncomplicated urinary tract infections: exploring differences in adherence to guidelines between three European countries. Drug Education Project Group.

    Veninga CC, Lundborg CS, Lagerløv P, Hummers-Pradier E, Denig P, Haaijer-Ruskamp FM.

    Ann Pharmacother. 2000 Jan;34(1):19-26.PMID: 10669181 [PubMed - indexed for MEDLINE]Related articles

    35.

    GPs' treatment of uncomplicated urinary tract infections--a clinical judgement analysis in four European countries. DEP group. Drug Education Project.

    Hummers-Pradier E, Denig P, Oke T, Lagerløv P, Wahlström R, Haaijer-Ruskamp FM.

    Fam Pract. 1999 Dec;16(6):605-7.PMID: 10625136 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Project Group.

    Veninga CC, Lagerløv P, Wahlström R, Muskova M, Denig P, Berkhof J, Kochen MM, Haaijer-Ruskamp FM.

    Am J Respir Crit Care Med. 1999 Oct;160(4):1254-62.PMID: 10508816 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Do physicians take cost into account when making prescribing decisions?

    Denig P, Haaijer-Ruskamp FM.

    Pharmacoeconomics. 1995 Oct;8(4):282-90. No abstract available. PMID: 10155670 [PubMed - indexed for MEDLINE]Related articles

    38.

    Impact of feedback and peer review on prescribing.

    Haaijer-Ruskamp FM, Denig P.

    Occas Pap R Coll Gen Pract. 1995 Feb;(69):13-9. No abstract available. PMID: 15852566 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Drug expectations and drug choices of hospital physicians.

    Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A.

    J Intern Med. 1993 Aug;234(2):155-63.PMID: 8340738 [PubMed - indexed for MEDLINE]Related articles

    40.

    Towards understanding treatment preferences of hospital physicians.

    Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A.

    Soc Sci Med. 1993 Apr;36(7):915-24.PMID: 8480237 [PubMed - indexed for MEDLINE]Related articles

    41.

    [On which criteria are drug choices by hospital physicians based?]

    Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A.

    Ned Tijdschr Geneeskd. 1993 Feb 27;137(9):448-51. Dutch. No abstract available. PMID: 8446212 [PubMed - indexed for MEDLINE]Related articles

    42.

    Therapeutic decision making of physicians.

    Denig P, Haaijer-Ruskamp FM.

    Pharm Weekbl Sci. 1992 Feb 21;14(1):9-15. Review.PMID: 1553253 [PubMed - indexed for MEDLINE]Related articles

    43.

    Prescribing pattern in a Dutch university hospital.

    Denig P, Haaijer-Ruskamp FM, Versluis A, Wesseling H.

    J Clin Pharm Ther. 1991 Dec;16(6):423-33.PMID: 1770070 [PubMed - indexed for MEDLINE]Related articles

    44.

    Impact of clinical trials on the adoption of new drugs within a university hospital.

    Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A.

    Eur J Clin Pharmacol. 1991;41(4):325-8.PMID: 1804648 [PubMed - indexed for MEDLINE]Related articles

    45.

    Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behavior of physicians.

    Denig P, Haaijer-Ruskamp FM, Zijsling DH.

    DICP. 1990 Jan;24(1):87-93.PMID: 2301192 [PubMed - indexed for MEDLINE]Related articles

    46.

    [The decision process of the family physician in the choice of a drug]

    Denig P, Haaijer-Ruskamp FM.

    Ned Tijdschr Geneeskd. 1989 Mar 25;133(12):632-3. Dutch. No abstract available. PMID: 2654655 [PubMed - indexed for MEDLINE]Related articles

    47.

    How physicians choose drugs.

    Denig P, Haaijer-Ruskamp FM, Zijsling DH.

    Soc Sci Med. 1988;27(12):1381-6.PMID: 3238456 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...